Title:
GLP-1 RECEPTOR AGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING SAME
Document Type and Number:
WIPO Patent Application WO/2022/216094
Kind Code:
A1
Abstract:
The present invention relates to: a novel compound having excellent GLP-1 agonist activity and an excellent DMPK profile, and thus useful as an agent for treating or preventing obesity or various metabolic diseases such as diabetes and hyperlipidemia; an isomer thereof or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the compound; and a method for preparing the compound.
More Like This:
Inventors:
KIM YOUNG KWAN (KR)
PARK JUN (KR)
JO MIN MI (KR)
PARK JUN (KR)
JO MIN MI (KR)
Application Number:
PCT/KR2022/005070
Publication Date:
October 13, 2022
Filing Date:
April 07, 2022
Export Citation:
Assignee:
LG CHEMICAL LTD (KR)
International Classes:
C07D401/10; A61K31/4184; A61K31/422; A61K31/4439; A61P3/00; A61P25/28; C07D401/14; C07D405/10; C07D405/14; C07D413/14
Domestic Patent References:
WO2020207474A1 | 2020-10-15 | |||
WO2020263695A1 | 2020-12-30 | |||
WO2018183112A1 | 2018-10-04 | |||
WO2021187886A1 | 2021-09-23 | |||
WO2021154796A1 | 2021-08-05 |
Foreign References:
KR20210020095A | 2021-02-23 |
Attorney, Agent or Firm:
LEE & KO IP (KR)
Download PDF:
Previous Patent: WEARABLE ELECTRONIC APPARATUS COMPRISING ANTENNA
Next Patent: DRONE FOR EMERGENCY SITUATION AND METHOD FOR CONTROLLING SAME
Next Patent: DRONE FOR EMERGENCY SITUATION AND METHOD FOR CONTROLLING SAME